All Stories

  1. Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: A systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials

    Article • PLoS ONE, June 2017, PLOS

    Carlos Moreira-Maia

  2. Evidence on methylphenidate in children and adolescents with ADHD is in fact of ‘very low quality’

    Article • Evidence-Based Mental Health, October 2016, BMJ

    Carlos Moreira-Maia

  3. Response to “Trust, but verify” by Banaschewski et al.

    Article • Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, September 2016, Hogrefe Publishing Group

    Carlos Moreira-Maia

  4. BDNF Val66Metpolymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorder

    Article • Acta Psychiatrica Scandinavica, May 2016, Wiley

    Carlos Moreira-Maia

  5. Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil

    Article • Brazilian Journal of Psychiatry, March 2016, FapUNIFESP (SciELO)

    Carlos Moreira-Maia

  6. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of harmful effects in non-randomised studies

    Article • Cochrane Database of Systematic Reviews, February 2016, Wiley

    Carlos Moreira-Maia

  7. Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis

    Article • American Journal of Psychiatry, January 2016, American Psychiatric Association

    Carlos Moreira-Maia

  8. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)

    Article • Cochrane Database of Systematic Reviews, November 2015, Wiley

    Carlos Moreira-Maia

  9. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials

    Article • BMJ, November 2015, BMJ

    Carlos Moreira-Maia

  10. Attention-deficit/hyperactivity disorder dimensionality: the reliable ‘g’ and the elusive ‘s’ dimensions

    Article • European Child & Adolescent Psychiatry, April 2015, Springer Science + Business Media

    Carlos Moreira-Maia, Pedro Mario Pan

  11. The Brazilian policy of withholding treatment for ADHD is probably increasing health and social costs

    Article • Brazilian Journal of Psychiatry, March 2015, FapUNIFESP (SciELO)

    Carlos Moreira-Maia

  12. Long-Term Efficacy of Methylphenidate for ADHD Children: A Systematic Review and Meta-Analysis

    Article • Journal of Attention Disorders, December 2014, SAGE Publications

    Carlos Moreira-Maia

  13. Prevalence of obesity in attention-deficit/hyperactivity disorder: study protocol for a systematic review and meta-analysis:

    Article • BMJ Open, March 2014, BMJ

    Carlos Moreira-Maia

  14. Economic evaluation in the field of mental health: conceptual basis

    Article • Brazilian Journal of Psychiatry, April 2013, FapUNIFESP (SciELO)

    Carlos Moreira-Maia

  15. REVIEW ARTICLE Mental health economics: Insights from Brazil

    Article • Journal of Mental Health, April 2013, Taylor & Francis

    Carlos Moreira-Maia

  16. Switching from methylphenidate immediate release to MPH-SODAS™ in attention-deficit/hyperactivity disorder

    Article • European Child & Adolescent Psychiatry, September 2007, Springer Science + Business Media

    Carlos Moreira-Maia

  17. Psicofármacos para o tratamento de transtornos de ansiedade em crianças e adolescentes: uma revisão sistemática

    Article • Brazilian Journal of Psychiatry, March 2007, FapUNIFESP (SciELO)

    Carlos Moreira-Maia

  18. Pharmacotherapy for the anxiety disorders in children and adolescents

    Article • Brazilian Journal of Psychiatry, March 2007, FapUNIFESP (SciELO)

    Carlos Moreira-Maia